TQC3721 inhalation powder Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2

Indications

COPD2
Pulmonary Disease, Chronic Obstructive1
Chronic Obstructive Pulmonary Disease (COPD)1

Other2 trials

A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease

Phase 1

A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.